导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.14% | 8/8 |
| 近一周 | -0.35% | 8/8 |
| 近一月 | -0.57% | 8/8 |
| 近一季 | 0.55% | 8/8 |
| 近半年 | 3.36% | 8/8 |
| 近一年 | 4.80% | 8/8 |
| 近两年 | 17.63% | 8/8 |
| 近三年 | 21.64% | 5/7 |
| 成立以来 | 66.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
1.39% 4/8 |
2.05% 8/8 |
2.12% 8/8 |
- - |
| 2024 | 8.73% 6/8 |
4.98% 6/8 |
1.55% 4/8 |
1.60% 6/8 |
0.40% 4/8 |
| 2023 | 6.67% 5/8 |
0.16% 7/7 |
4.64% 3/7 |
-1.61% 4/8 |
3.44% 8/8 |
| 2022 | 4.61% 2/7 |
1.88% 4/7 |
-2.20% 2/7 |
0.73% 3/7 |
4.22% 4/7 |
| 2021 | 23.64% 4/7 |
10.91% 25/312 |
10.86% 54/328 |
0.08% 93/358 |
0.49% 7/7 |
| 2020 | -4.17% 8/8 |
-23.39% 224/280 |
12.77% 143/295 |
-1.45% 210/299 |
12.55% 85/305 |
| 2019 | - - |
- - |
2.70% 95/267 |
1.85% 96/253 |
3.32% 168/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 华夏海外聚享混合发起式(QDII-FOF)C人民币 VS. () |